1,870
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Reduction in the Treatment Gap for Breast Cancer in Mexico under Seguro Popular, 2007 to 2016

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: e2064794 | Received 24 Oct 2021, Accepted 07 Apr 2022, Published online: 22 Jun 2022

References

  • Global Cancer Observatory https://gco.iarc.fr/ Accessed 01 Feb 2022. Lyon, France: GLOBOCAN Database, IARC (International Agency for Research in Cancer); 2020.
  • NOM 041-SSA2-2011: norma Oficial Mexicana para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Secretaría de Salud, México 2011. Available online: http://dof.gob.mx/nota_detalle.php?codigo=5194157&fecha=09/06/2011 Accessed 01 Feb 2022.
  • Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Seattle (United States): Institute for Health Metrics and Evaluation (IHME; 2020.
  • Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, Correa-Rotter R, Rivera JA, Barquera S, Gonzalez-Pier E, et al. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2016;388(10058):2386–9. doi:10.1016/S0140-6736(16)31773-1.
  • Gomez Dantes O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. The health system of Mexico. Salud Publica Mex. 2011; 53(Suppl 2): s220–232. https://saludpublica.mx/index.php/spm/article/view/5043/10023.
  • González Block MA, Reyes Morales H, Cahuana Hurtado L, Balandrán A, Méndez E, Allin S. Mexico: health system review. Health Systems in Transition. 2020;22:i–222.
  • Aracena-Genao B, Gonzalez-Robledo MC, Gonzalez-Robledo LM, Palacio-Mejia LS, Nigenda-Lopez G. Fund for protection against catastrophic expenses. Salud Publica Mex. 2011;53(Suppl 4):407–15. doi:10.1590/s0036-36342011001000004.
  • Chemor Ruiz A, Ratsch AEO, Alamilla Martinez GA. Mexico’s Seguro Popular: achievements and challenges. Health Syst Reform. 2018;4(3):194–202. doi:10.1080/23288604.2018.1488505.
  • Catálogo Universal de Servicios de Salud. 2018. Anexo I: intervenciones del Fondo de Protección contra Gastos Catastróficos. Mexico: Comisión Nacional de Protección en Salud http://www.documentos.seguro-popular.gob.mx/dgss/CAUSES_2018c.pdf Accessed 01 Feb 2022.
  • Kale R. The treatment gap. Epilepsia. 2002;43(Suppl 6):31–33. doi:10.1046/j.1528-1157.43.s.6.13.x.
  • Kohn R, Ali AA, Puac-Polanco V, Figueroa C, Lopez-Soto V, Morgan K, Saldivia S, Vicente B. Mental health in the Americas: an overview of the treatment gap. Rev Panam Salud Publica. 2018;42:e165. doi:10.26633/RPSP.2018.165. PMC6386160.
  • Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bruffaerts R, Chiu WT, Florescu S, de Girolamo G, Gureje O, et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO world mental health (WMH) surveys. Psychol Med. 2018;48(9):1560–71. doi:10.1017/S0033291717003336. PMC6878971.
  • Reich MR. Restructuring health reform, Mexican style. Health Syst Reform. 2020;6(1):1–11. doi:10.1080/23288604.2020.1763114.
  • Agren D. Farewell Seguro Popular. Lancet. 2020;395(10224):549–50. doi:10.1016/S0140-6736(20)30408-6.
  • Instituto de Salud para el Bienestar, Gobierno de México. ( Cited 2021May16) Available at: https://www.gob.mx/insabi/que-hacemos.
  • INEGI (Instituto Nacional de Estadística y Geografía). XII Censo General de Población y Vivienda 2000, México [ cited 2021 May 2]. Available from: https://inegi.org.mx/programas/ccpv/2000/.
  • INEGI (Instituto Nacional de Estadística y Geografía). Censo de Población y Vivienda 2010, México [ cited 2021 May 2]. Available from: https://inegi.org.mx/programas/ccpv/2010/.
  • INEGI (Instituto Nacional de Estadística y Geografía). Encuesta Intercensal 2015, México (cited 2021 May 2). Available from: https://www.inegi.org.mx/programas/intercensal/2015/.
  • ENSANUT (Encuesta Nacional de Salud y Nutrición) 2006. Instituto Nacional de Salud Pública, México. [Cited 2021 May 2]. Available from: https://ensanut.insp.mx/encuestas/ensanut2006/descargas.php.
  • ENSANUT (Encuesta Nacional de Salud y Nutrición) 2012. Instituto Nacional de Salud Pública, México. [Cited 2021 May 2]. Available from: https://ensanut.insp.mx/encuestas/ensanut2012/descargas.php.
  • Global Burden of Disease Collaborative Network. Global burden of disease study 2017 (GBD 2017) results. Seattle (United States): Institute for Health Metrics and Evaluation (IHME), 2018. (cited 2021 May 3) Available from http://ghdx.healthdata.org/gbd-results-tool.
  • Reynoso-Noveron N, Villarreal-Garza C, Soto-perez-de-celis E, Arce-Salinas C, Matus-Santos J, Ramirez-Ugalde MT, Alvarado-Miranda A, Cabrera-Galeana P, Meneses-Garcia A, Lara-Medina F, et al. Clinical and Epidemiological profile of breast cancer in Mexico: results of the Seguro Popular. J Glob Oncol. 2017;3(6):757–64. doi:10.1200/JGO.2016.007377. PMC5735969.
  • Lozano R, Garrido F. Improving health system efficiency: Mexico. Catastrophic health expenditure fund https://apps.who.int/iris/handle/10665/186476 . . 2015 (Geneva: World Health Organization) Accessed 2 May 2021 Health Systems Governance and Funding
  • Unger-Saldana K, Ventosa-Santaularia D, Miranda A, Verduzco-Bustos G. Barriers and explanatory mechanisms of delays in the patient and diagnosis intervals of care for breast cancer in Mexico. Oncologist. 2018;23(4):440–53. doi:10.1634/theoncologist.2017-0431. PMC5896704.
  • Huerta-Gutierrez R, Lajous M, Zamora-Muñoz S, Hernández-Ávila JE, Mohar A, Muñoz-Aguirre P. Breast cancer survival disparities in Mexican women under a comprehensive health reform. JCO Global Oncology. 2020;6(Supplement_1):67–67. doi:10.1200/go.20.64000.
  • Bandala-Jacques A, Huerta-Gutierrez R, Muñoz SZ, Cabrera P, Mohar A, Lajous M. Abstract 47: survival of breast cancer in women treated under Mexico’s Seguro Popular. Cancer Epidemiol Biomarker and Prev. 2021;30(7_Supplement):47–47. doi:10.1158/1538-7755.ASGCR21-47.
  • Villarreal-Garza C, Aranda-Gutierrez A, Ferrigno AS, Platas A, Aloi-Timeus I, Mesa-Chavez F, Ayensa-Alonso A, Platas A. The challenges of breast cancer care in Mexico during health-care reforms and COVID-19. Lancet Oncol. 2021;22(2):170–71. doi:10.1016/S1470-2045(20)30609-4. PMC8080161.